Phibro Animal Health (PAHC) has been a very strong performer for us, up 20% and now above my $35 target.

However, I do not see much upside from here, as I think currencies and commodity prices could negatively impact next week’s earnings report. Therefore, now is a good time to take profits. Sell PAHC at market.